GlassScriptPhysician profile
Elizabeth A Malone
NPI 1639250970
$1,186.77
in general payments reported to CMS, 2019-2025
23 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $263 · 2023: $173 · 2024: $153 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.11 | 2021-2023 | |
| Gilead Sciences, INC. | $122.88 | 2025 | Epclusa |
| Shield Therapeutics INC | $114.88 | 2024 | |
| Organon LLC | $114.85 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $63.61 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $60.57 | 2021-2022 | |
| Evofem Biosciences, INC. | $59.91 | 2022-2025 | Phexxi, Solosec, Phexx |
| Amgen INC. | $53.76 | 2021 | |
| Astellas Pharma US INC | $46.88 | 2023 | Veozah |
| Ethicon US, LLC | $37.48 | 2021-2023 | Enseal |
| Avanos Medical | $29.44 | 2021 | |
| Mayne Pharma Commercial LLC | $28.10 | 2025 | |
| Medtronic, INC. | $26.62 | 2023 | V-Loc 180 |
| Avion Pharmaceuticals | $22.42 | 2022 | |
| Coopersurgical, INC. | $21.14 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $18.86 | 2021 | |
| Becton, Dickinson and Company | $18.85 | 2021 | |
| Biogen, INC. | $18.56 | 2025 | Zurzuvae |
| Acessa Health INC. | $17.63 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.21 | 2022 | |
| Therapeuticsmd, INC. | $16.28 | 2021 | |
| Pfizer INC. | $15.89 | 2022 | |
| Merck Sharp & Dohme LLC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.